mTOR inhibitor
Results Trial description recap V1

Everolimus - Temsirolimus - Temsirolimus


Advanced breast cancer (metastatic)

all type of patients 4 trials

first line therapy 1 trials

patients recurring or progressing after prior endocrine therapy 2 trials

patient trastuzumab-resistant, and previously treated by taxanes 1 trials

HR+ HER2- 3 trials

Renal-cell carcinoma (advanced)

all type of patients 4 trials

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons